Pharmaceutical
Healthcare
Health

Merck

$82.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.66 (-0.80%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Merck and other stocks, options, ETFs, and crypto commission-free!

About

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. Read More The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species, which it sells to veterinarians, distributors, and animal producers. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the Company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Employees
69,000
Headquarters
Kenilworth, New Jersey
Founded
1891
Market Cap
213.34B
Price-Earnings Ratio
35.48
Dividend Yield
2.60
Average Volume
10.94M
High Today
$83.45
Low Today
$82.02
Open Price
$82.91
Volume
2.98M
52 Week High
$83.45
52 Week Low
$52.83

Collections

Pharmaceutical
Healthcare
Health
Medical
Manufacturing
Health And Wellness
Technology
Therapy

News

The Motley Fool11h

3 Cancer Treatment Stocks to Buy in March

There has been tremendous progress in the battle against cancer, but it remains the second leading cause of death in the U.S., behind heart disease.

154
Markets InsiderMar 22

Applied LifeSciences & Systems Announces Closing of its $8 Million Series A Round of Equity Financing

RALEIGH, N.C., March 22, 2019 /PRNewswire/ -- Applied LifeSciences & Systems (ALSS) announced today the close of an $8 million Series A round of equity financing.

54
Seeking AlphaMar 22

Merck Portfolio: Halftime Report

This portfolio is lagging the market so far due to two forms of drag from the hedging. After the success of a hedged portfolio built around an AT&T position in 2017, I started presenting similar portfolios built around other conservative stocks, including Merck in 2018. Image via Merck's Twitter page. A Hedged Portfolio Around An Merck Position Last August, I wrote about the performance of a bulletproof, or hedged, portfolio built around a position in AT&T (T) in 2017 and presented a new one, which comp...

39

Earnings

$0.87
$0.98
$1.08
$1.19
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 30, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.